Isbn: 9780826142061 - the aprn and pa's complete guide to prescribing drug therapy 2024 (3 Ergebnisse)

ISBN
Mit der Detailsuche verfeinern

Optimieren Sie Ihre Suche

  • Bücher (3)

bis

Benutzerdefinierte Preisspanne (EUR)

bis

  • Sprache: Englisch

    Verlag: Springer Publishing Company, 2024

    0826142060 / 9780826142061

    • Softcover

    Anbieter: Books From California, Simi Valley, CA, USABooks From California

    Verkäufer/-in mit 4 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Gebraucht - Gut

    EUR 34,06

    EUR 4,35 Versand 
    Versand innerhalb von USA

    Anzahl: 1 verfügbar

    paperback. Zustand: Very Good.

  • Sprache: Englisch

    Verlag: Springer Publishing Company, 2024

    0826142060 / 9780826142061

    • Softcover

    Anbieter: Revaluation Books, Exeter, Vereinigtes KönigreichRevaluation Books

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 92,05

    EUR 14,58 Versand 
    Versand von Vereinigtes Königreich nach USA

    Anzahl: 2 verfügbar

    Paperback. Zustand: Brand New. 6th new edition. 750 pages. 9.00x6.00x9.00 inches. In Stock.

  • Sprache: Englisch

    Verlag: Springer Publishing Company Jan 2024, 2024

    0826142060 / 9780826142061

    • Softcover

    Anbieter: AHA-BUCH GmbH, Einbeck, DeutschlandAHA-BUCH GmbH

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 135,99

    EUR 30,50 Versand 
    Versand von Deutschland nach USA

    Anzahl: 2 verfügbar

    Taschenbuch. Zustand: Neu. Neuware - An unrivaled reference tool for advanced practice providers and students in clinical practice settingsThis concise and easy-to-read drug therapy prescribing reference provides critical information for advanced practice nurses and physician assistants in clinical practice settings who are involved in the primary care management of patients with acute, episodic, and chronic health problems, life-altering and life-threatening diseases, and needs for health promotion and disease prevention. Interspersed with clinically useful information, such as monitored laboratory values, patient teaching points, and safety information, this reference draws upon data taken directly from FDA-approved drug labels and patient medication guides, and is organized by diagnosis rather than by drug classification, to provide advanced practice practitioners with the comprehensive, concise, and up-to-date information on drug therapies that they need to help achieve positive outcomes in their daily practice.The first section of this book presents drug treatment regimens for over 700 clinical diagnoses, listed alphabetically by generic name, followed by important information required for prescription decision-making. The second section provides additional information on treatment, organized in a convenient table format. An alphabetical cross-reference index of drugs allows for easy identification of alternate drug names and their location within the text. Purchase includes online access via most mobile devices or computers.New to this Edition: - Information on over 100 new diagnoses and over 100 new generic drugs indicated for the treatment of quality of life-altering and life-threatening conditions such as chronic kidney disease, genetic diseases, mesothelioma, MS, metastatic cancers, and rare diseases.- Updates on drugs used for site-specific cancers, mental health issues, and commonly diagnosed diseases such as diabetes and asthma.- Details on new drug approvals including indications, treatment regimens, adverse reactions, drug-drug interactions, warnings and precautions, and use in special populationsKey Features:- Provides new drug treatment regimens for drugs that are first in class, novel drugs, orphan drugs, new drugs with breakthrough or fast track designation and drugs with new indications and expanded social populations.- Includes drug prescribing information on diseases prevalent outside of North America, including endemic diseases with known transmission and treatment interventions.- Serves advanced practice providers across the United States and internationally.- Consistent with approvals and recommendations for use by the FDA.